Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Moffat

Showing results (41-50 of 195) with videos related to

Pageof 20
Sort By:
Neuro-Oncology Advances|November 12, 2021
Identification of five important genes to predict glioblastoma subtypesYang Tang, Maleeha A Qazi, Kevin R Brown, et al.
Apoptosis : an International Journal on Programmed Cell Death|April 11, 2012
A genome wide shRNA screen identifies α/β hydrolase domain containing 4 (ABHD4) as a novel regulator of anoikis resistanceCraig D Simpson, Rose Hurren, Dahlia Kasimer, et al.
Pancreas|July 16, 2013
Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinomaNardin Samuel, Azin Sayad, Gavin Wilson, et al.
The American Journal of Pathology|March 5, 2014
CD133-targeted niche-dependent therapy in cancer: a multipronged approachAnthony B Mak, Caroline Schnegg, Chiou-Yan Lai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2013
Targeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticlesShawn C Owen, Nish Patel, Jennifer Logie, et al.
Journal of Molecular Biology|February 22, 2014
Post-translational regulation of CD133 by ATase1/ATase2-mediated lysine acetylationAnthony B Mak, Mariana Pehar, Allison M L Nixon, et al.
Cell Systems|May 18, 2023
Reproducibility metrics for context-specific CRISPR screensMaximilian Billmann, Henry N Ward, Michael Aregger, et al.
Genome Medicine|August 29, 2014
A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screeningJouhyun Jeon, Satra Nim, Joan Teyra, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2025
CRISPR-Cas9-Guided Genetic Manipulation of Patient-Derived Brain Tumor CellsYujin Suk, Erika Apel, Stefan Custers, et al.
Nature Chemical Biology|February 23, 2016
Pooled screening for antiproliferative inhibitors of protein-protein interactionsSatra Nim, Jouhyun Jeon, Carles Corbi-Verge, et al.
Pageof 20

Showing results (41-50 of 195) with videos related to

Sort By:
Pageof 20
Neuro-Oncology Advances|November 12, 2021
Identification of five important genes to predict glioblastoma subtypesYang Tang, Maleeha A Qazi, Kevin R Brown, et al.
Apoptosis : an International Journal on Programmed Cell Death|April 11, 2012
A genome wide shRNA screen identifies α/β hydrolase domain containing 4 (ABHD4) as a novel regulator of anoikis resistanceCraig D Simpson, Rose Hurren, Dahlia Kasimer, et al.
Pancreas|July 16, 2013
Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinomaNardin Samuel, Azin Sayad, Gavin Wilson, et al.
The American Journal of Pathology|March 5, 2014
CD133-targeted niche-dependent therapy in cancer: a multipronged approachAnthony B Mak, Caroline Schnegg, Chiou-Yan Lai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2013
Targeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticlesShawn C Owen, Nish Patel, Jennifer Logie, et al.
Journal of Molecular Biology|February 22, 2014
Post-translational regulation of CD133 by ATase1/ATase2-mediated lysine acetylationAnthony B Mak, Mariana Pehar, Allison M L Nixon, et al.
Cell Systems|May 18, 2023
Reproducibility metrics for context-specific CRISPR screensMaximilian Billmann, Henry N Ward, Michael Aregger, et al.
Genome Medicine|August 29, 2014
A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screeningJouhyun Jeon, Satra Nim, Joan Teyra, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2025
CRISPR-Cas9-Guided Genetic Manipulation of Patient-Derived Brain Tumor CellsYujin Suk, Erika Apel, Stefan Custers, et al.
Nature Chemical Biology|February 23, 2016
Pooled screening for antiproliferative inhibitors of protein-protein interactionsSatra Nim, Jouhyun Jeon, Carles Corbi-Verge, et al.
Pageof 20